GBDMF yields 3.37% · PFE yields 6.13%● Live data
📍 GBDMF pulled ahead of the other in Year 1
Combined, GBDMF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GBDMF + PFE for your $10,000?
Global Dominion Access, S.A. provides multi-technical services and specialized engineering solutions in Spain and internationally. The company engages in the provision of operation and maintenance services for industries, and infrastructures and businesses; industrial cleaning maintenance services; installation and maintenance of refractory linings; design, construction, and maintenance of tall structures, including towers, silos, domes, chimneys, stacks, and others; designing, building, and maintaining industrial structures, such as gas systems, tanks and vessels, industrial furnaces, and electrical systems; and management of logistics and warehouses. It also provides solutions for flexible production and automation; hospital waste incineration; telecommunication networks; technological projects and communication systems; renewable energy generation; and self-consumption and new energy systems. In addition, the company is involved in the implementation and integral management of the life cycle of distribution and transmission lines; installation and integration of the technological items at hospitals, including medical equipment and clinical furniture, as well as the IT system infrastructure and service management platforms; technology and services distribution for the household; and marketing of electricity, gas, mobile, fiber, insurance, and other services for the household. Further, it provides monitored operation management, a solution that implements and manages ICS platforms that use technology as a tool to guarantee and improve the system and process efficiency; digital transformation services; and maintenance and repair services for businesses and the household. It serves the telecommunications, industrial, energy, household, and infrastructure sectors. The company was incorporated in 1999 and is headquartered in Bilbao, Spain.
Full GBDMF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.